Jiangsu Hengrui Medicine
600276.SS
#494
Rank
A$64.67 B
Marketcap
$10.14
Share price
-0.62%
Change (1 day)
10.44%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Jiangsu Hengrui Medicine (600276.SS) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : A$0.91 Billion

According to Jiangsu Hengrui Medicine 's latest financial reports the company's total liabilities are A$0.91 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Jiangsu Hengrui Medicine - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31A$0.83 B5.02%
2021-12-31A$0.79 B1.73%
2020-12-31A$0.78 B46.81%
2019-12-31A$0.53 B0.3%
2018-12-31A$0.53 B29.36%
2017-12-31A$0.41 B41.91%
2016-12-31A$0.29 B20.56%
2015-12-31A$0.24 B31.01%
2014-12-31A$0.18 B76.1%
2013-12-31A$0.10 B50.54%
2012-12-31A$69.45 M1.85%
2011-12-31A$68.19 M8.85%
2010-12-31A$62.64 M15.15%
2009-12-31A$54.4 M13.76%
2008-12-31A$47.83 M-24.23%
2007-12-31A$63.12 M93.19%
2006-12-31A$32.67 M8.92%
2005-12-31A$29.99 M-25.42%
2004-12-31A$40.22 M-54.84%
2003-12-31A$89.07 M5.26%
2002-12-31A$84.61 M-1%
2001-12-31A$85.47 M